99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1

Product Details
Customization: Available
CAS No.: 697761-98-1
Formula: 697761-98-1
Still deciding? Get samples of US$ 1/kg
Request Sample
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
  • 99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
Find Similar Products

Basic Info.

Model NO.
Elvitegravir
EINECS
697761-98-1
Grade
Pharm
Function
Other
Certification
MSDS, FDA, GMP
Usage
Cosmetic Raw Materials, for Lab Use
Raw Material
Others
Transport Machine
Ordinary Goods Truck
Appearance
White or off-White Crystalline Powder
Transport Package
Drum
Specification
USP36 EP8
Trademark
Recedar
Origin
China
HS Code
0000
Production Capacity
1000kg

Product Description

99% high purity API raw powder Elvitegravir with CAS 697761-98-1
99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
 
Elvitegravir
Chemical name:
:(S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLICACI
CAS No.:697761-98-1
Molecular formula: C23H23ClFNO5
Molecular weight:447.88
EINECS No.:1592732-453-0

Etigovir is a class of integrase inhibitors and the first anti-AIDS drug of the quinolone class.

HIV integrase inhibitors are the third class of anti-HIV drugs discovered after nucleoside/non-nucleoside anti-reverse transcriptase inhibitors and protease inhibitors. The first integrase inhibitor was Leitgevir developed by Merck and was approved by the FDA for HIV/AIDS infection in 2007. The elvitegravir developed by Gilead is the second integrase inhibitor approved by FDA Chemicalbook in 2012 after Leitgevir, and it is also the first anti-HIV quinolone integrase inhibitor. The virological effects of these two drugs are similar, but elvitegravir only needs to be taken orally once a day, which is more compliant than retegvir (twice a day). Viruses that are resistant to other anti-AIDS drugs can also be suppressed, with good compliance and tolerance.
99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1

  
Package carton drum with two plastic bags inside
Net weight 25KG/Drum
Storage Sealed in cool and dry place to avoid moisture and light
Shelf life 2 years when properly stored
Lead time 1~3 days after confirmation

99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
TESTS SPECIFICATIONS
Appearance Pale-yellow to off-white powder
Identification HNMR
LOD(% w/w) ≤0.5%
Purity (HPLC) ≥99%
 
More reports, please contact us freely.

99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1


99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1
99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-199% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1

99% Purity API Raw Powder Etigovir Elvitegravir with CAS 697761-98-1

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier